SciTech Development Secures $3.2M for Oncology Development and Operations

SciTech Development Raises Additional Funding

Key Highlights:

• Funding Round: Raised an additional $3.2 million in funding, bringing the total amount to $12 million.
• Investors: Funding led by Storm Lake Capital and Pointe Angels.
• Focus on Oncology: SciTech Development is a clinical-stage pharmaceutical company specializing in oncology treatments.

SciTech Development's Target Market

• Target Market: Oncology healthcare providers, hospitals, and research institutions.
• Treatment of T-Cell Lymphomas: Focus on developing innovative treatments for T-cell lymphomas, a form of non-Hodgkin lymphoma.
• Improving Drug Delivery: Utilizing nanoparticle drug delivery platform (SDP) to enhance the bioavailability of water-insoluble therapeutics.

What SciTech Development Needs to Buy

• Clinical Research and Trials: Collaborating with research institutions and clinical trial partners for the advancement of their oncology treatments.
• Manufacturing and Supply Chain Solutions: Partnering with manufacturers to ensure efficient production and distribution of their pharmaceutical products.
• Regulatory Compliance Services: Engaging with regulatory experts to navigate the complex process of obtaining necessary approvals and certifications.